Fortrea Holdings Inc. (FTRE)
Last updated: 2026-10-24 06:10:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Fortrea Holdings Inc. (FTRE) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $23.61, with a market capitalization of $2.27B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.55 to $28.27. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.27B | |
$23.92 | |
$41.02 | |
$3.97 | |
$23.92 | |
755.47K | |
1.61M | |
-- | |
$28.27 | |
$8.55 | |
-- | |
-- |
Fortrea Holdings Inc. (FTRE) Latest Closing Stock Price
Fortrea Holdings Inc. (FTRE) last closed at $23.92 as of 2026-10-23 23:42:00, unchanged from the previous close of $23.92.
During the latest regular trading session, FTRE traded between $3.97 and $41.02, with a volume of 755.47K shares. The closing price was near the middle and near the upper end of its 52-week range.
Fortrea Holdings Inc. (FTRE) 7-Day Stock Price Change
Over the past seven days, Fortrea Holdings Inc. (FTRE) moved from $22.75 to $23.61, representing a gain of 3.81% ($0.87).
The stock traded between $21.63 and $28.27 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 2.04 million shares, up versus the previous seven-day period, indicating higher trading activity.
FTRE 52-Week Price Position
Position in Range: 76.4%
FTRE is currently trading at $23.61, placing it 76.4% of the way from its 52-week low of $8.55 to its 52-week high of $28.27. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Fortrea Holdings Inc. (FTRE)?
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Fortrea Holdings Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 14000 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Fortrea Holdings Inc. (FTRE) Stock on MEXC
Eligible investors can buy real shares of Fortrea Holdings Inc. (FTRE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Fortrea Holdings Inc. (FTRE) stock price today?
2.Is FTRE stock going up or down today?
3.What is FTRE pre-market price?
4.What is FTRE after-hours price?
5.Is FTRE stock trading now?
6.Where does FTRE sit relative to its 52-week high and low?
7.What sector is Fortrea Holdings Inc. in?
8.What is Fortrea Holdings Inc.'s market capitalization and where is it listed?
9.How is FTRE valued in terms of P/E ratio and EPS?
10.Does Fortrea Holdings Inc. pay a dividend?
Explore More US Stocks
Search Stocks
FTRE Stock Calculator
Estimate the value between FTRE shares and USD.
FTRE Shares to USD
1.00 FTRE shares = 23.611 USD
Calculations are estimates based on the latest available price and are for reference only.


